Skip to content
Wednesday 12 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,833.15
-0.10%
DAX
26,331.07
-0.23%
CAC 40
8,674.94
-0.46%
STOXX 50
6,533.99
-0.26%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Friday 29 August 2014 10:21 am  |  Updated:  Friday 07 June 2019 6:18 am

Ebola spreads to Senegal

By: Sarah Spickernell

Add as a preferred source on Google

The Ebola epidemic has reached a fifth West African country.
 
Senegal's Ministry of Health confirmed its first case of of the disease today, which puts Senegal alongside Guinea, Liberia, Sierra Leone and Nigeria in the list of countries affected by the outbreak.
 
The infected person was a young man from Guinea, according to health minister Awa Marie Coll Seck. She added that he was immediately placed in quarantine.
 
Over 1,500 cases and 800 deaths have been confirmed since the outbreak began in Guinea in February, and the World Health Organisation (WHO) has warned the situation is worsening.
 
This morning, West African ministers called for Ebola-related travel bans to be lifted, but at a conference today, the UN's health agency offered new evidence to suggest that the spread of the disease is accelerating, saying that there was a greater increase in the number of cases during the last week than in any week prior to that.
 
As it outlined a plan to stop transmission in the next six to nine months, it warned that 20,000 people could be infected before the outbreak subsides. 

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Ebola

Trending Articles

  • Martin Williams on his favourite Toast the City venues

  • Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

  • Burnham’s devolution drive could ‘push 90,000 jobs out of London’

  • ‘Absurd’: Government seeks quantum tech chief – no experience necessary

  • BM3EAC Corp. 2026 Semi-Annual Report

More from Morning Wire

  • Ryanair warns of ‘passport queue chaos’ with new EU border system

    Aviation
    Elon Musk and Ryanair CEO Michael O’Leary face off amid acquisition rumors in a business meeting setting
  • Grindr for Equality Commits to Connecting 10M to HIV Prevention by 2028

    Business Wire
  • Compass Pathways to Announce Second Quarter and First Half 2026 Financial Results on August 5, 2026

    Business Wire
  • Insulet Partners with Calm to Bring Mindfulness and Well-Being Tools to the Diabetes Community, Featuring a New Sleep Story Narrated by Lila Moss

    Business Wire
  • AngloGold Ashanti Q2 30 June 2026 Earnings Release and Dividend Declaration

    Business Wire
  • VoxNeuro Receives FDA 510(k) Clearance for Cognitive Function Neuroimaging (cfNI) Software – An Objective EEG/ERP Brain Health Assessment

    Business Wire
  • InterSystems Recognized as a Leader in the Gartner® Magic Quadrant™ for Enterprise Electronic Health Records

    Business Wire
  • As it happened: Stocks reach all-time high; US fires back at ‘surprise’ Iran attacks

    Markets
    LSEG logo on a large screen within a modern building displaying stock market data and world indices
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook